FDA OKs first treatment for rare genetic disorder
The Food and Drug Administration has approved the first treatment for children and adults with spinal muscular atrophy, a rare genetic disorder marked by progressive muscle weakness that's the most common genetic cause of death in infants.
from Biotech News
0 Comments